In this Healthed lecture, A/Prof John Litt AM provides an overview on the zostavax vaccine uptake in Australia, the recombinant zoster vaccine, and the burden of morbidity.
This educational activity was developed by Healthed at the request of and with funding from GSK.
Based on this educational activity, complete these learning modules to gain additional CPD.
Browse the latest podcasts from Healthed.
You have completed the Educational Activities component of this resource.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
